跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Bayer Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 9, 2023
Approval ID
40b500bb8b5f4daf
Company
Bayer Ag
Type
Standard
Approval Details
Approval Id
40b500bb8b5f4daf
Drug Cima Aemps Name
ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
13907013IP
Holder Company Name
Bayer Ag
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/bayer-ag
Authorization Date
2023-03-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Bayer Ag
Company Detail Path
/organization/bayer-ag
Company Information
Pharmaceutical Company Name
BAYER AG
Name En
Bayer AG
Country Name
Germany
City Name
Leverkusen
Address
Leverkusen, North Rhine-Westphalia, Germany
Website
https://www.bayer.com
Active Ingredients
RIOCIGUAT
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 9, 2023
Approval ID
40b500bb8b5f4daf
Type
Standard
Back to CIMA-AEMPS Approvals
